Zimbabwe: Comedians Raise Funds for Cancer Patient

[The Herald] No contribution is too small for Takudzwa Paradza, who was diagnosed with a high degree of Non-Hodgkin's Lymphoma in September last year and has since gone through numerous chemotherapy sessions. Comedians across the nation have decided to join hands to help fund-raise the remaining $3 000 which the young man needs for treatment.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news

Related Links:

Clin Lymphoma Myeloma Leuk. 2021 Oct 15:S2152-2650(21)02383-1. doi: 10.1016/j.clml.2021.10.003. Online ahead of print.ABSTRACTAggressive B-cell lymphomas including diffuse large B-cell lymphoma make up the majority of non-Hodgkin's lymphoma globally. While more than half of these patients can be cured with modern chemoimmunotherapy regimens, the outcomes of relapsed or refractory disease continue to be very poor. Despite significant developments in targeted cancer therapies and immuno-oncology, the attainability of a cure remained an elusive goal outside of incorporating high doses of chemotherapy followed by hematopoietic...
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Source Type: research
adi Non-Hodgkin Lymphoma accounts for >460,000 cases and >240,000 deaths globally and >77,000 cases and >20,000 deaths in the U.S. annually, with ~85% of cases being B-cell malignancies. Until recently, patients with relapsed/refractory B-cell lymphoma following standard chemotherapy in combination with anti-CD20 monoclonal antibodies and autologous stem cell transplantation experienced a median overall survival (OS) of <6 months. However, with the approval of four different CD-19 CAR-T therapies between 2017 and 2021, approximately 60–80% of patients receiving CAR-T therapy now...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research
AbstractHealth-related quality of life (HRQoL) is a multidimensional concept including physical, emotional, social, and cognitive functions, disease symptoms, and side effects of treatment. Differences in HRQoL due to gender, existence of comorbidities, and number of chemotherapy cycles are little explored in diffuse large B-cell lymphoma (DLBCL) survivors. Our objective was to investigate whether differences in HRQoL in function of these factors exist 1 year after the diagnosis of DLBCL. One hundred and one patients, enrolled in the RT3 (Real-Time Tailored Therapy) Study, answered self-administrated European Organization ...
Source: Annals of Hematology - Category: Hematology Source Type: research
This article presents a review of Hodgkin lymphoma and non-Hodgkin lymphoma. These two common haematology diagnoses are frequently suspected by GPs and non-cancer professionals, and subsequently treated by haematologists and chemotherapy outpatient departments across the country. It is therefore important for all health professionals, including nurses in all settings, to be aware of the main characteristics of both of these lymphomas. There are strong similarities and striking differences between the disease processes, the presenting symptoms, prognostics and treatment pathways. The age of presentation in each is markedly ...
Source: British Journal of Nursing - Category: Nursing Authors: Source Type: research
Front Oncol. 2021 Sep 16;11:706331. doi: 10.3389/fonc.2021.706331. eCollection 2021.ABSTRACTIncreasing evidence suggests that the gut microbiome is associated with both cancer chemotherapy (CTX) outcomes and adverse events (AEs). This review examines the relationship between the gut microbiome and CTX as well as the impact of CTX on the gut microbiome. A literature search was conducted in electronic databases Medline, PubMed and ScienceDirect, with searches for "cancer" and "chemotherapy" and "microbiome/microbiota". The relevant literature was selected for use in this article. Seventeen studi...
Source: Genomics Proteomics ... - Category: Genetics & Stem Cells Authors: Source Type: research
This article presents a review of Hodgkin lymphoma and non-Hodgkin lymphoma. These two common haematology diagnoses are frequently suspected by GPs and non-cancer professionals, and subsequently treated by haematologists and chemotherapy outpatient departments across the country. It is therefore important for all health professionals, including nurses in all settings, to be aware of the main characteristics of both of these lymphomas. There are strong similarities and striking differences between the disease processes, the presenting symptoms, prognostics and treatment pathways. The age of presentation in each is markedly ...
Source: British Journal of Nursing - Category: Nursing Authors: Source Type: research
Front Oncol. 2021 Sep 16;11:706331. doi: 10.3389/fonc.2021.706331. eCollection 2021.ABSTRACTIncreasing evidence suggests that the gut microbiome is associated with both cancer chemotherapy (CTX) outcomes and adverse events (AEs). This review examines the relationship between the gut microbiome and CTX as well as the impact of CTX on the gut microbiome. A literature search was conducted in electronic databases Medline, PubMed and ScienceDirect, with searches for "cancer" and "chemotherapy" and "microbiome/microbiota". The relevant literature was selected for use in this article. Seventeen studi...
Source: Genomics Proteomics ... - Category: Genetics & Stem Cells Authors: Source Type: research
This article presents a review of Hodgkin lymphoma and non-Hodgkin lymphoma. These two common haematology diagnoses are frequently suspected by GPs and non-cancer professionals, and subsequently treated by haematologists and chemotherapy outpatient departments across the country. It is therefore important for all health professionals, including nurses in all settings, to be aware of the main characteristics of both of these lymphomas. There are strong similarities and striking differences between the disease processes, the presenting symptoms, prognostics and treatment pathways. The age of presentation in each is markedly ...
Source: British Journal of Nursing - Category: Nursing Authors: Source Type: research
Front Oncol. 2021 Sep 16;11:706331. doi: 10.3389/fonc.2021.706331. eCollection 2021.ABSTRACTIncreasing evidence suggests that the gut microbiome is associated with both cancer chemotherapy (CTX) outcomes and adverse events (AEs). This review examines the relationship between the gut microbiome and CTX as well as the impact of CTX on the gut microbiome. A literature search was conducted in electronic databases Medline, PubMed and ScienceDirect, with searches for "cancer" and "chemotherapy" and "microbiome/microbiota". The relevant literature was selected for use in this article. Seventeen studi...
Source: Genomics Proteomics ... - Category: Genetics & Stem Cells Authors: Source Type: research
This article presents a review of Hodgkin lymphoma and non-Hodgkin lymphoma. These two common haematology diagnoses are frequently suspected by GPs and non-cancer professionals, and subsequently treated by haematologists and chemotherapy outpatient departments across the country. It is therefore important for all health professionals, including nurses in all settings, to be aware of the main characteristics of both of these lymphomas. There are strong similarities and striking differences between the disease processes, the presenting symptoms, prognostics and treatment pathways. The age of presentation in each is markedly ...
Source: British Journal of Nursing - Category: Nursing Authors: Source Type: research
More News: African Health | Cancer | Cancer & Oncology | Chemotherapy | Health | Lymphoma | Non-Hodgkin's Lymphoma